步长制药：产品续约成功保留在国家医保目

Core Viewpoint - The company, Buchang Pharma, successfully retained its drugs Xuanfei Baidu Granules and Danhong Injection in the National Medical Insurance Directory for 2025, ensuring continued access to these products under national health insurance programs [1] Group 1: Drug Information - Xuanfei Baidu Granules are indicated for clearing heat and detoxifying the lungs, used for epidemic diseases caused by damp-heat obstructing the lungs, with symptoms including fever, cough, and shortness of breath [1] - Danhong Injection is used for promoting blood circulation and alleviating blood stasis, indicated for conditions such as chest pain and stroke, with symptoms including chest tightness and limb numbness [1]